Lazard Asset Management’s AdaptHealth AHCO Stock Holding History

Lazard Asset Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$458K	Sell	43,980 -1,625,474	-97%	-$18.1M	﹤0.01%	1462
2026 Q1	$19.9M	Buy	1,669,454 +432,664	+35%	+$4.43M	0.03%	326
2025 Q4	$12.3M	Buy	1,236,790 +167,730	+16%	+$1.6M	0.02%	386
2025 Q3	$9.57M	Buy	1,069,060 +382,340	+56%	+$3.54M	0.01%	435
2025 Q2	$6.47M	Buy	686,720 +635,713	+1,246%	+$5.61M	0.01%	661
2025 Q1	$552K	Buy	51,007 +50,847	+31,779%	+$512K	﹤0.01%	1382
2024 Q4	$1K	Sell	160 -145	-48%	-$1.47K	﹤0.01%	2201
2024 Q3	$3K	Sell	305 -4,023	-93%	-$42.8K	﹤0.01%	2068
2024 Q2	$43K	Buy	+4,328	New	+$44K	﹤0.01%	1950
2023 Q1	–	Sell	-2,487	Closed	-$47K	–	2275
2022 Q4	$47K	Sell	2,487 -196,736	-99%	-$4.16M	﹤0.01%	1845
2022 Q3	$3.74M	Sell	199,223 -7,839	-4%	-$161K	0.01%	767
2022 Q2	$3.73M	Buy	+207,062	New	+$3.36M	0.01%	785

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lazard Asset Management's AHCO Position: Q2 2026 in Review

Lazard Asset Management reduced its AdaptHealth (AHCO) stake by 97% in Q2 2026, selling an estimated $18.1M and leaving 43,980 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Lazard Asset Management first reported a position in AHCO in Q2 2022 and has held it in 12 quarters since. The position peaked at $19.9M in Q1 2026. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

Lazard Asset Management held 43,980 shares of AdaptHealth worth $458K as of Q2 2026.
Lazard Asset Management sold 1,625,474 AdaptHealth shares in Q2 2026, an estimated $18.1M.
AdaptHealth made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1462 holding.
Lazard Asset Management first reported a position in AdaptHealth in Q2 2022 and has held it in 12 quarters since.
Lazard Asset Management's AdaptHealth position peaked at $19.9M in Q1 2026.
238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.